by admin | Jan 18, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
A world-first trial is investigating if stem cell transplantation could be used in patients with aggressive multiple sclerosis (MS) as a first-line treatment. By University of Sheffield The study launched by the University of Sheffield and Sheffield Teaching Hospitals...
by admin | Jan 17, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
CIRM grant will fund novel gene therapy aiming for one-time, lifelong treatment of Friedreich’s ataxia, a progressive neuromuscular disorder; second CIRM grant will advance efforts to leverage UC San Diego research on another rare disease By Scott LaFee – UC San...
by admin | Jan 13, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By EPFL News A new study by scientists at the .NeuroRestore research center has identified the type of neuron that is activated and remodeled by spinal cord stimulation, allowing patients to stand up, walk and rebuild their muscles – thus improving their quality of...
by admin | Jan 12, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Researchers at the Beckman Institute for Advanced Science and Technology developed a new method to ‘see’ the fine structure and chemical composition of a human cell with unmatched clarity and precision. By Jenna Kurtzweil – University of Illinois Beckman...
by admin | Jan 11, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Meredith Wadman – Science New law welcomed by animal welfare groups, but others say change won’t happen fast New medicines need not be tested in animals to receive U.S. Food and Drug Administration (FDA) approval, according to legislation signed by President...
by admin | Jan 11, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Press Office – King’s College London – neurosciencenews.com Summary: Results of a phase three clinical trial of a novel brain cancer vaccine, DCVax-L, that uses a patient’s stem cells to target cancer cells extended survival by many months to years for...
